EAHAD 2025 4 - 7 February 2025

Efficacy and safety of concizumab prophylaxis in patients with haemophilia and inhibitors: Results from the Early Access Program in France

Authors :

Alexandre Butelet1; Nicolas Béranger2; Vincent Cussac2; Roseline d’Oiron3-6; Yesim Dargaud4-5; Victoria Delerue2; Stéphanie Desage5; Caroline Galeotti3; Sophie Susen7; Valérie Chamouard4-5

Affiliations
View Details Hide Details
Keywords
Rare Blood Disorders
Congress poster
Concizumab